Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Geron regains rights to telomerase inhibitors from Pharmacia; forms new division

Jan. 30, 2001

Somatostatin and neuromedin B receptor agonists and their use

Jan. 29, 2001

New isocoumarins with antiangiogenic activity claimed by Korean scientists

Jan. 29, 2001

Selective aromatase inhibitors show promise in early or preventive breast cancer treatment

Jan. 29, 2001

Apoptosis inducers emerge from R&D at Nippon Kayaku

Jan. 26, 2001

Neurim team discovers new melatonin-related compounds with unique profile

Jan. 26, 2001

New Isis antisense compounds modulate hnRNP A1 expression

Jan. 26, 2001

NDA for abarelix depot officially filed by FDA; drug assigned priority review status

Jan. 26, 2001

Introgen awarded SBIR grant to study INGN-241 as lung cancer treatment

Jan. 25, 2001

Tamoxifen for breast cancer prevention does not alter cardiovascular risk

Jan. 25, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...